The relatively high prevalence of peripheral sensor-motor neuropathy in our cohort of patients could be, among others, due to the use of anti-TNFα biologics in all of our patients, which is in correlation with available studies on the role of anti-TNFα biologics in the etiopathogenesis of peripheral neuropathy in CD [21, 22]. Here, TNF is linked to peripheral neuropathy.